iPSCs derived from infertile men carrying complex genetic abnormalities can generate primordial germ-like cells.
Fiche publication
Date publication
août 2022
Journal
Scientific reports
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CALLIER Patrick, Mr DUFFOURD Yannis
Tous les auteurs :
Mouka A, Arkoun B, Moison P, Drévillon L, Jarray R, Brisset S, Mayeur A, Bouligand J, Boland-Auge A, Deleuze JF, Yates F, Lemonnier T, Callier P, Duffourd Y, Nitschke P, Ollivier E, Bourdin A, De Vos J, Livera G, Tachdjian G, Maouche-Chrétien L, Tosca L
Lien Pubmed
Résumé
Despite increasing insight into the genetics of infertility, the developmental disease processes remain unclear due to the lack of adequate experimental models. The advent of induced pluripotent stem cell (iPSC) technology has provided a unique tool for in vitro disease modeling enabling major advances in our understanding of developmental disease processes. We report the full characterization of complex genetic abnormalities in two infertile patients with either azoospermia or XX male syndrome and we identify genes of potential interest implicated in their infertility. Using the erythroblasts of both patients, we generated primed iPSCs and converted them into a naive-like pluripotent state. Naive-iPSCs were then differentiated into primordial germ-like cells (PGC-LCs). The expression of early PGC marker genes SOX17, CD-38, NANOS3, c-KIT, TFAP2C, and D2-40, confirmed progression towards the early germline stage. Our results demonstrate that iPSCs from two infertile patients with significant genetic abnormalities are capable of efficient production of PGCs. Such in vitro model of infertility will certainly help identifying causative factors leading to early germ cells development failure and provide a valuable tool to explore novel therapeutic strategies.
Mots clés
Azoospermia, genetics, Cell Differentiation, genetics, Erythroblasts, Germ Cells, metabolism, Humans, Induced Pluripotent Stem Cells, metabolism, Male
Référence
Sci Rep. 2022 08 22;12(1):14302